These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 19852620)

  • 21. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
    Miller AL
    Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning.
    Besunder JB; Super DM; Anderson RL
    J Pediatr; 1997 Jun; 130(6):966-71. PubMed ID: 9202621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
    Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
    Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
    Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
    Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chelation therapy to treat lead toxicity in children.
    Wegmann K
    Minn Med; 1992 Nov; 75(11):25-7. PubMed ID: 1331737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data.
    Thurtle N; Greig J; Cooney L; Amitai Y; Ariti C; Brown MJ; Kosnett MJ; Moussally K; Sani-Gwarzo N; Akpan H; Shanks L; Dargan PI
    PLoS Med; 2014 Oct; 11(10):e1001739. PubMed ID: 25291378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonists for acute oral cadmium chloride intoxication.
    Basinger MA; Jones MM; Holscher MA; Vaughn WK
    J Toxicol Environ Health; 1988; 23(1):77-89. PubMed ID: 2826797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats.
    Flora SJ; Mehta A; Rao PV; Kannan GM; Bhaskar AS; Dube SN; Pant BP
    Toxicology; 2004 Feb; 195(2-3):127-46. PubMed ID: 14751669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of zinc supplementation during chelation treatment of lead intoxication in rats.
    Flora SJ; Tandon SK
    Toxicology; 1990 Nov; 64(2):129-39. PubMed ID: 2171159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of combined meso 2,3-dimercaptosuccinic acid and calcium disodium edetate treatment during acute lead intoxication in rats.
    Flora GJ; Seth PK; Prakash AO; Mathur R
    Hum Exp Toxicol; 1995 May; 14(5):410-3. PubMed ID: 7612302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modest and variable efficacy of pre-exposure hydroxocobalamin and dicobalt edetate in a porcine model of acute cyanide salt poisoning.
    Thompson A; Dunn M; Jefferson RD; Dissanayake K; Reed F; Gregson R; Greenhalgh S; Clutton RE; Blain PG; Thomas SH; Eddleston M
    Clin Toxicol (Phila); 2020 Mar; 58(3):190-200. PubMed ID: 31389254
    [No Abstract]   [Full Text] [Related]  

  • 34. Lead detoxification activities of a class of novel DMSA--amino acid conjugates.
    Xu Y; Wang Y; Wang L; Zhao M; Zhang X; Hu X; Hou B; Peng L; Zheng M; Wu J; Peng S
    Chem Res Toxicol; 2011 Jun; 24(6):979-84. PubMed ID: 21591669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
    Bhadauria S; Flora SJ
    Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
    Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coenzyme Q
    Mwaeni VK; Nyariki JN; Jillani N; Omwenga G; Ngugi M; Isaac AO
    BMC Pharmacol Toxicol; 2021 Apr; 22(1):19. PubMed ID: 33827703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chelation in metal intoxication--Principles and paradigms.
    Aaseth J; Skaug MA; Cao Y; Andersen O
    J Trace Elem Med Biol; 2015; 31():260-6. PubMed ID: 25457281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of micronutrients used along with DMSA in the treatment of moderately lead intoxicated mice.
    Liao Y; Yu F; Jin Y; Lu C; Li G; Zhi X; An L; Yang J
    Arch Toxicol; 2008 Jan; 82(1):37-43. PubMed ID: 17721779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.